Based on the latest genome-wide association summary statistics for severe COVID-19, a recent study indicated an increased risk of severe COVID-19 for individuals who had genetically raised levels of circulating ACE2 protein (Yang et al., 2022). This evidence concerns the gene ACE2 and COVID-19.